These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8457193)

  • 1. Evidence for common structural changes in thrombin induced by active-site or exosite binding.
    Parry MA; Stone SR; Hofsteenge J; Jackman MP
    Biochem J; 1993 Mar; 290 ( Pt 3)(Pt 3):665-70. PubMed ID: 8457193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of regions of alpha-thrombin involved in its interaction with hirudin.
    Stone SR; Braun PJ; Hofsteenge J
    Biochemistry; 1987 Jul; 26(15):4617-24. PubMed ID: 3663613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The fifth and sixth growth factor-like domains of thrombomodulin bind to the anion-binding exosite of thrombin and alter its specificity.
    Ye J; Liu LW; Esmon CT; Johnson AE
    J Biol Chem; 1992 Jun; 267(16):11023-8. PubMed ID: 1317850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allosteric changes of thrombin catalytic site induced by interaction of bothrojaracin with anion-binding exosites I and II.
    Monteiro RQ; Rapôso JG; Wisner A; Guimarães JA; Bon C; Zingali RB
    Biochem Biophys Res Commun; 1999 Sep; 262(3):819-22. PubMed ID: 10471408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probing the hirudin-thrombin interaction by incorporation of noncoded amino acids and molecular dynamics simulation.
    De Filippis V; Colombo G; Russo I; Spadari B; Fontana A
    Biochemistry; 2002 Nov; 41(46):13556-69. PubMed ID: 12427016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allosteric changes in solvent accessibility observed in thrombin upon active site occupation.
    Croy CH; Koeppe JR; Bergqvist S; Komives EA
    Biochemistry; 2004 May; 43(18):5246-55. PubMed ID: 15122890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The isomorphous structures of prethrombin2, hirugen-, and PPACK-thrombin: changes accompanying activation and exosite binding to thrombin.
    Vijayalakshmi J; Padmanabhan KP; Mann KG; Tulinsky A
    Protein Sci; 1994 Dec; 3(12):2254-71. PubMed ID: 7756983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet glycoprotein Ib alpha binds to thrombin anion-binding exosite II inducing allosteric changes in the activity of thrombin.
    Li CQ; Vindigni A; Sadler JE; Wardell MR
    J Biol Chem; 2001 Mar; 276(9):6161-8. PubMed ID: 11024046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of exosite occupancy on the substrate specificity of thrombin.
    Ng NM; Quinsey NS; Matthews AY; Kaiserman D; Wijeyewickrema LC; Bird PI; Thompson PE; Pike RN
    Arch Biochem Biophys; 2009 Sep; 489(1-2):48-54. PubMed ID: 19638274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the thrombin insertion loop 144-155. Study of thrombin mutations W148G, K154E and a thrombin-based synthetic peptide.
    Bouton MC; Plantier JL; Dembak M; Guillin MC; Rabiet MJ; Jandrot-Perrus M
    Eur J Biochem; 1995 Apr; 229(2):526-32. PubMed ID: 7744076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of hirudin to meizothrombin.
    Fischer BE; Schlokat U; Himmelspach M; Dorner F
    Protein Eng; 1998 Aug; 11(8):715-21. PubMed ID: 9749925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombin interaction with a recombinant N-terminal extracellular domain of the thrombin receptor in an acellular system.
    Bouton MC; Jandrot-Perrus M; Moog S; Cazenave JP; Guillin MC; Lanza F
    Biochem J; 1995 Jan; 305 ( Pt 2)(Pt 2):635-41. PubMed ID: 7832783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bothrojaracin: a potent two-site-directed thrombin inhibitor.
    Arocas V; Zingali RB; Guillin MC; Bon C; Jandrot-Perrus M
    Biochemistry; 1996 Jul; 35(28):9083-9. PubMed ID: 8703912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structures of thrombin complexes with a designed and a natural exosite peptide inhibitor.
    Qiu X; Yin M; Padmanabhan KP; Krstenansky JL; Tulinsky A
    J Biol Chem; 1993 Sep; 268(27):20318-26. PubMed ID: 8376390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular recognition by thrombin. Role of the slow-->fast transition, site-specific ion binding energetics and thermodynamic mapping of structural components.
    Ayala Y; Di Cera E
    J Mol Biol; 1994 Jan; 235(2):733-46. PubMed ID: 8289292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for allosteric linkage between exosites 1 and 2 of thrombin.
    Fredenburgh JC; Stafford AR; Weitz JI
    J Biol Chem; 1997 Oct; 272(41):25493-9. PubMed ID: 9325262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteolytic formation of either of the two prothrombin activation intermediates results in formation of a hirugen-binding site.
    Liu LW; Ye J; Johnson AE; Esmon CT
    J Biol Chem; 1991 Dec; 266(35):23633-6. PubMed ID: 1748641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allosteric changes in thrombin's activity produced by peptides corresponding to segments of natural inhibitors and substrates.
    Hortin GL; Trimpe BL
    J Biol Chem; 1991 Apr; 266(11):6866-71. PubMed ID: 1849894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bifunctional peptide boronate inhibitors of thrombin: crystallographic analysis of inhibition enhanced by linkage to an exosite 1 binding peptide.
    Skordalakes E; Elgendy S; Goodwin CA; Green D; Scully MF; Kakkar VV; Freyssinet JM; Dodson G; Deadman JJ
    Biochemistry; 1998 Oct; 37(41):14420-7. PubMed ID: 9772168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystallographic structure of human gamma-thrombin.
    Rydel TJ; Yin M; Padmanabhan KP; Blankenship DT; Cardin AD; Correa PE; Fenton JW; Tulinsky A
    J Biol Chem; 1994 Sep; 269(35):22000-6. PubMed ID: 8071320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.